Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_assertion description "[Concurrent promotor hypermethylation of p16INK4a and p14ARF correlated significantly with tumor size, lymph node metastasis, and stage III/IV advanced OSCC; p14ARF hypermethylation, in particular, was significantly associated with both lymph node metastasis and late clinical stage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_assertion evidence source_evidence_literature NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_assertion SIO_000772 15975525 NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_assertion wasDerivedFrom befree-2016 NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_assertion wasGeneratedBy ECO_0000203 NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.
- befree-2016 importedOn "2016-02-19" NP500750.RAmR0HlHM6WXeoEUIrAVgfxE6s1ONnABFeEn7SQeWZKQM130_provenance.